Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
2
×
alphabet
bio
biotech
boston blog main
boston top stories
broad institute of harvard and mit
brook byers
charles chu
crispr
crispr cas14
deals
decheng capital
diagnostic
google
infectious disease
investing
kleiner perkins
life sciences
mammoth biosciences
mayfield
medical devices
national blog main
national top stories
nfx
patent
san francisco
san francisco blog main
san francisco top stories
sherlock biosciences
sunny balwani
tc
theranos
trevor martin
university of california berkeley
university of california san francisco
verily
What
bio
2
×
diagnostics
2
×
analysis
available
based
beleaguered
big
biosciences
blood
cas
cheaper
chief
claims
company
coo
crispr
currently
develop
expects
faster
federal
investigation
making
mammoth
medical
misleading
officer
operating
organizational
overhauls
read
reorganizes
retires
set
startup
stepping
structure
tech
technology
theranos
Language
unset
Current search:
bio
×
startups
×
diagnostics
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@techcrunch.com
7 years ago
Theranos’ COO retires as the troubled bio-tech startup overhauls its organizational structure
